Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 74 (2024): Issue 2 (June 2024)
Open Access
Deprescribing: An umbrella review
Nuša Japelj
Nuša Japelj
,
Nejc Horvat
Nejc Horvat
,
Lea Knez
Lea Knez
and
Mitja Kos
Mitja Kos
| May 30, 2024
Acta Pharmaceutica
Volume 74 (2024): Issue 2 (June 2024)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
May 30, 2024
Page range:
249 - 267
Accepted:
Jan 04, 2024
DOI:
https://doi.org/10.2478/acph-2024-0011
Keywords
deprescription
,
drug discontinuation
,
drug withdrawal
,
drug tapering
,
umbrella review
© 2024 Nuša Japelj et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Nuša Japelj
University of Ljubljana Faculty of Pharmacy, Department of Social Pharmacy
Ljubljana, Slovenia
Nejc Horvat
University of Ljubljana Faculty of Pharmacy, Department of Social Pharmacy
Ljubljana, Slovenia
Lea Knez
University of Ljubljana Faculty of Pharmacy, Department of Social Pharmacy
Ljubljana, Slovenia
University Clinic Golnik,
Golnik, Slovenia
Mitja Kos
University of Ljubljana Faculty of Pharmacy, Department of Social Pharmacy
Ljubljana, Slovenia